MCP
TECH icon

Meridiem Capital Partners’s Bio-Techne TECH Stock Holding History

Meridiem Capital Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-402,227
Closed -$21M – 115
2026
Q1 		$21M Buy
402,227
+147,868
+58% +$8.88M 1.37% 28
2025
Q4 		$15M Buy
254,359
+43,412
+21% +$2.64M 0.9% 38
2025
Q3 		$11.7M Buy
+210,947
New +$11.3M 0.75% 47
2025
Q2 		– Sell
-290,180
Closed -$17M – 91
2025
Q1 		$17M Buy
+290,180
New +$19.7M 1.77% 22

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Meridiem Capital Partners's TECH Position: Q2 2026 in Review

Meridiem Capital Partners sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 402,227 shares — an estimated $21M sold.

Meridiem Capital Partners first reported a position in TECH in Q1 2025 and held it in 4 quarters. The position peaked at $21M in Q1 2026. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Meridiem Capital Partners reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Meridiem Capital Partners sold 402,227 Bio-Techne shares in Q2 2026, an estimated $21M.
  • Meridiem Capital Partners first reported a position in Bio-Techne in Q1 2025 and held it in 4 quarters.
  • Meridiem Capital Partners's Bio-Techne position peaked at $21M in Q1 2026.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Meridiem Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.